European Research Initiative on CLL
Project 7 (WP7) of the European LeukemiaNet (ELN) and
EHA Scientific Working Group (SWG)
ERIC is a European organization devoted to improve the outcome of patients with chronic lymphocytic leukemia (CLL) and related diseases.
There are many more open questions and new drugs available in the treatment of CLL than study groups or active protocols. To achieve faster progress, open communication between study groups, physicians and scientists is a key element.
ERIC is a Working Party of the European LeukemiaNet and a Scientific Working Group of the European Hematology Association. ERIC is OPEN to all physicians and scientists working/interested in the field of chronic lymphocytic leukemia and related disorders.